| Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis RJ Colman, DT Rubin Journal of Crohn's and Colitis 8 (12), 1569-1581, 2014 | 624 | 2014 |
| Safety and efficacy of combination treatment with calcineurin inhibitors and vedolizumab in patients with refractory inflammatory bowel disease B Christensen, PR Gibson, D Micic, RJ Colman, SR Goeppinger, ... Clinical Gastroenterology and Hepatology 17 (3), 486-493, 2019 | 92 | 2019 |
| Histological inflammation increases the risk of colorectal neoplasia in ulcerative colitis: a systematic review RJ Colman, DT Rubin Intestinal research 14 (3), 202, 2016 | 71 | 2016 |
| Vedolizumab as induction and maintenance for inflammatory bowel disease: 12-month effectiveness and safety B Christensen, RJ Colman, D Micic, PR Gibson, SR Goeppinger, A Yarur, ... Inflammatory bowel diseases 24 (4), 849-860, 2018 | 51 | 2018 |
| Real‐world infliximab pharmacokinetic study informs an electronic health record‐embedded dashboard to guide precision dosing in children with Crohn’s disease Y Xiong, T Mizuno, R Colman, J Hyams, JD Noe, B Boyle, YT Tsai, ... Clinical Pharmacology & Therapeutics 109 (6), 1639-1647, 2021 | 48 | 2021 |
| Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel disease RJ Colman, DT Rubin Journal of Crohn's and Colitis 9 (4), 312-317, 2015 | 41 | 2015 |
| Methotrexate for the treatment of pediatric Crohn’s disease: a systematic review and meta-analysis RJ Colman, RC Lawton, MC Dubinsky, DT Rubin Inflammatory bowel diseases 24 (10), 2135-2141, 2018 | 39 | 2018 |
| Surveillance of IBD using high definition colonoscopes does not miss adenocarcinoma in patients with low-grade dysplasia N Krugliak Cleveland, RJ Colman, D Rodriquez, A Hirsch, RD Cohen, ... Inflammatory bowel diseases 22 (3), 631-637, 2016 | 30 | 2016 |
| Antibodies‐to‐infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn’s disease RJ Colman, Y Xiong, T Mizuno, JS Hyams, JD Noe, B Boyle, GR D’Haens, ... Alimentary pharmacology & therapeutics 55 (5), 593-603, 2022 | 26 | 2022 |
| Agreement between patient-and physician-completed Pediatric Ulcerative Colitis Activity Index scores JJ Lee, RJ Colman, PD Mitchell, ML Atmadja, A Bousvaros, JR Lightdale Journal of pediatric gastroenterology and nutrition 52 (6), 708-713, 2011 | 25 | 2011 |
| Achieving target infliximab drug concentrations improves blood and fecal neutrophil biomarkers in Crohn’s disease RJ Colman, YT Tsai, K Jackson, BM Boyle, JD Noe, JS Hyams, ... Inflammatory Bowel Diseases 27 (7), 1045-1051, 2021 | 23 | 2021 |
| Favorable outcomes and anti-TNF durability after addition of an immunomodulator for anti-drug antibodies in pediatric IBD patients RJ Colman, A Portocarrero-Castillo, D Chona, J Hellmann, P Minar, ... Inflammatory Bowel Diseases 27 (4), 507-515, 2021 | 22 | 2021 |
| Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia. JE Ollech, RJ Colman, D Rodriquez, A Hirsch, RD Cohen, SB Hanauer, ... Clinical Gastroenterology and Hepatology: the Official Clinical Practice …, 2018 | 19 | 2018 |
| Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2014; 8 (12): 1569–81 RJ Colman, DT Rubin Go to original source... Go to PubMed, 0 | 16 | |
| Tu1350 vedolizumab in the treatment of IBD: the University of Chicago experience B Christensen, SR Goeppinger, RJ Colman, D Siddiqui, A Yarur, ... Gastroenterology 148 (4), S-866, 2015 | 13 | 2015 |
| HLA-DQA1* 05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysis V Solitano, A Facciorusso, DPB McGovern, T Nguyen, RJ Colman, L Zou, ... Clinical Gastroenterology and Hepatology, 2023 | 12 | 2023 |
| Efficacy and Follow-up of Sub-Total Colectomy With Ileo-Rectal Anastomoses in Patients With Colitis-associated Neoplasia NK Cleveland, JE Ollech, RJ Colman, D Rodriquez, A Hirsch, RD Cohen, ... Clinical gastroenterology and hepatology: the official clinical practice …, 2019 | 12 | 2019 |
| Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab … RJ Colman, T Mizuno, K Fukushima, DB Haslam, JS Hyams, B Boyle, ... Alimentary Pharmacology & Therapeutics 57 (5), 524-539, 2023 | 10 | 2023 |
| Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 8: 1569–1581 RJ Colman, DT Rubin Gastroenterology 116, 1246-1249, 2014 | 10 | 2014 |
| Predicting therapeutic response in pediatric ulcerative colitis—a journey towards precision medicine RJ Colman, J Dhaliwal, MJ Rosen Frontiers in pediatrics 9, 634739, 2021 | 9 | 2021 |
David RubinUniversity of ChicagoVerified email at medicine.bsd.uchicago.edu
